Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection

被引:31
作者
Silveira, H
Ordway, D
Dockrell, H
Jackson, M
Ventura, F
机构
[1] UNIV NOVA LISBOA, IHMT, CTR MALARIA & OUTRAS DOENCAS TROPICAIS, P-1200 LISBON, PORTUGAL
[2] HOSP EGAS MONIZ, LISBON, PORTUGAL
[3] UNIV NOVA LISBOA, FAC CIENCIAS MED, P-1200 LISBON, PORTUGAL
关键词
mycobacteria; HIV; cytokine; cellular immune response;
D O I
10.1046/j.1365-2249.1997.5091407.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocyte proliferation and cytokine responses induced by a panel of mycobacterial antigens were compared in Portuguese donors with pulmonary tuberculosis (TB) with or without HIV co-infection, HIV+ patients and healthy Mantoux-positive controls. Control donors showed stronger proliferative responses than any of the patient groups, with secreted antigens (Mycobacterium tuberculosis (Mtb) 30 kD and short-term culture filtrate proteins (ST-CFP)), purified protein derivative (PPD) and Mtb H37Rv Sonicate (MtbS) inducing the strongest proliferation. Patients with pulmonary TB showed lower proliferation to PPD or to the 30-kD antigen. Responses to all the antigens (PPD, ST-CFP, MtbS, 70 kD, 65 kD, 38 kD, 30 kD and 10 kD) were higher in TB/HIV patients with CD4 counts greater than or equal to 200 CD4(+) T cells/ mm(3) compared with HIV alone (CD4 greater than or equal to 200 T cells/mm(3)), but were lost in both TB/HIV and HIV patients when CD4 counts fell below 200 T cells/mm(3). Measurements of interferon-gamma (IFN-gamma) in culture supernatants revealed that PPD, 30 kD, MtbS and ST-CFP induced the strongest Th1 response. Analysis of mRNA for IFN-gamma, IL-4 and IL-10 confirmed that IFN-gamma production was maintained in patients with pulmonary TB without any concomitant increase in IL-4 or IL-10 mRNA expression, although expression of IL-10 mRNA was increased ig HIV infection was present. These results reveal that IFN-gamma production is retained in pulmonary TB patients to a broad range of mycobacterial antigens, and that no switch to IL-4 production is seen even with HIV infection. Secreted antigens, and in particular ST-CFP, were the best inducers of IFN-gamma secretion-confirming their role in protective responses to Mlb.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 32 条
[1]   2-YEAR INCIDENCE OF TUBERCULOSIS IN COHORTS OF HIV-INFECTED AND UNINFECTED URBAN RWANDAN WOMEN [J].
ALLEN, S ;
BATUNGWANAYO, J ;
KERLIKOWSKE, K ;
LIFSON, AR ;
WOLF, W ;
GRANICH, R ;
TAELMAN, H ;
VANDEPERRE, P ;
SERUFILIRA, A ;
BOGAERTS, J ;
SLUTKIN, G ;
HOPEWELL, PC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (06) :1439-1444
[2]  
ANDERSEN P, 1995, J IMMUNOL, V154, P3359
[3]  
BARNES PF, 1992, J IMMUNOL, V148, P1835
[4]  
BARNES PF, 1996, CURR TOP MICROBIOL I, V215, P297
[5]   HUMAN T-CELL RESPONSES TO SECRETED ANTIGEN FRACTIONS OF MYCOBACTERIUM-TUBERCULOSIS [J].
BOESEN, H ;
JENSEN, BN ;
WILCKE, T ;
ANDERSEN, P .
INFECTION AND IMMUNITY, 1995, 63 (04) :1491-1497
[6]   THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1994, 15 (12) :575-581
[7]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[8]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765
[9]   PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION [J].
DELPRETE, GF ;
DECARLI, M ;
MASTROMAURO, C ;
BIAGIOTTI, R ;
MACCHIA, D ;
FALAGIANI, P ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :346-350
[10]  
DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213